Finally, based on both in vitro and in vivo data, we could conclude that lncRNA-SNHG6 promotes HCC progression by miR-6509-5p/HIF1A axis, and provided novel potential targets for the development of HCC drugs. The gene discussed is SNHG6; the disease is hepatocellular carcinoma.